# US 2013/0157993 A1 · Use of 5alpha-androstane (alkyl)-3beta,5,6beta-triol in preparation of neuroprotective drugs

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0157993 A1
- Document ID: US20130157993A1
- Status: Published application
- Kind: A1
- Application number: 13/805,436
- Filed: 2011-07-08
- Published: 2013-06-20
- Earliest claimed: 2010-07-09
- Assignees: Guangzhou Cellprotek Pharmaceutical Co., Ltd.
- Inventors: Guangmei Yan; Haiyan Hu; Tiandong Leng; Hanfei Sang; Jingxia Zhang; Pengxin Qiu; Shujia Zhou; Jiesi Chen; Xiuhua You
- Web page: https://patentgrep.com/patent/US20130157993A1

## CPC

- A61K 31/568: substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 25/00: Drugs for disorders of the nervous system
- C07J 1/0007: {not substituted in position 17}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07J: STEROIDS (seco-steroids C07C)

## Abstract

Disclosed is the use of 5α-androstane(alkyl)-3β,5,6β-triol in preparing neuroprotective drugs. The compound has significant protective effect against neuron injuries caused by cerebral ischemia, spinal cord isehemia or hypoxia and has no obvious toxic reaction within effective dose thereof.

## Claims

### Claim at position 1

1-4. (canceled)

### Claim 5

A method for treating a neuron related disease, comprising administering to a subject in need of the treatment a pharmaceutical composition comprising 5α-androstane(alkyl)-3β,5,6β-triol:

### Claim 6 (depends on 1)

The method of claim 1, wherein the neuron related disease is cerebral ischemia.

### Claim 7

The method of claim , wherein the neuron related disease is spinal cord ischemic.

### Claim 8 (depends on 1)

The method of claim 1, wherein the neuron related disease is neuron damage caused by hypoxia.
